<DOC>
	<DOCNO>NCT00510419</DOCNO>
	<brief_summary>The purpose research study evaluate investigational auto-injector system deliver sumatriptan skin single migraine attack . The study could take approximately 5 week include 3 office visit study doctor , patient contact every 2 week patient experience migraine use auto-injector . The last visit do telephone follow-up call .</brief_summary>
	<brief_title>A Study Assess Auto-injector Being Used Treat Migraine Attack</brief_title>
	<detailed_description>Investigational Plan : 1 . Screening Visit [ Visit 0 / 0-14 day prior receipt study drug ] 2 . Baseline Visit [ Visit 1 / Provision study drug subject training ] 3 . Treatment Visit [ Visit 2 / within 72 hour study drug administration ] 4 . Follow-up Visit [ Visit 3 / Telephone follow-up 7-10 day study drug administration ]</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>1 . Adults 18 60 year age 2 . Prior effective use injectable sumatriptan least two occasion within last two month 3 . At least two migraine per month suitable injectable sumatriptan 4 . Capable use migraine selfinjection autoinjector 5 . Capable distinguish migraine headache type ( e.g. , tensiontype headache ) 1 . Seizure disorder 2 . Coronary artery disease ( CAD ) 3 . Cardiac dysrhythmia pacemaker 4 . High blood pressure 5 . Liver disease 6 . Kidney disease 7 . Autoimmune disease 8 . History alcohol substance abuse 9 . Currently pregnant 10 . Use investigational drug product within 30 day prior treatment visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Migraine</keyword>
</DOC>